Pillar Biosciences
VerifiedPillar Biosciences is prized with its patent-pending targeted sequencing technology platform.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$119—178m (Dealroom.co estimates May 2020.)
Natick Massachusetts (HQ)
Get premium to view all results
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | investor | $0.0 | round |
| investor | $0.0 | round | |
| investor | $0.0 | round | |
* | $29.7m | Series C | |
| Total Funding | 000k | ||
Related Content
Recent News about Pillar Biosciences
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.